At Tilray, we remain deeply committed to providing the best patient service and offerings in the industry. Today we are excited to unveil a broad-based line of 20 different medical cannabis extract products, which will be available for sale soon. Each of the products offers more precise control over dosage as well as convenient consumption methods, and many result in longer-lasting effects than smoking or vaporizing. Pending Health Canada approval, we plan to begin offering these products to our patients soon.
Our line of extract products are being produced using state-of-the art, cold-extraction methods to preserve delicate cannabinoid and terpene content. The products will include:
  • Drops (available in Sativa, Indica, Hybrid and two varieties of CBD) for convenient ingestion and the option of infusing cannabis into many foods.
  • Liquid capsules (available in Sativa, Indica, Hybrid and two varieties of CBD) for easy ingestion and precise dosage.
  • Vaporizer oil (available in two varieties of CBD) for inhalation and ease of use via vaporization, which is an alternative to smoking. Subject to approval from Health Canada, this product will be available in a pre-filled vaporizer cartridge.
  • Oral spray (available in Sativa, Indica, Hybrid and CBD) for quick onset of effects; both convenient and fast-acting.
  • Topical oil (available in Hybrid and two varieties of CBD) for direct skin application and localized use.
We feel it is important to provide our patients with advance notice to ensure they are able to plan how they want to use their monthly allotment. We will be sharing more details about the timing of the product launch and pricing in the coming weeks.

As these extract products are new to the legal marketplace, our patient support team is available to answer any questions 24 hours a day, 7 days a week, 365 days a year at 1-844-TILRAY1 (845-7291) or tilray@tilray.ca.